Harvard Apparatus Regenerative Technology Inc.
HRGN
$1.54
$0.0030.20%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 604.44% | -82.56% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 604.44% | -82.56% | |||
| Cost of Revenue | 815.15% | -81.14% | |||
| Gross Profit | 25.00% | -85.54% | |||
| SG&A Expenses | 5.54% | -8.02% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 25.36% | 5.67% | |||
| Operating Income | -9.76% | -22.34% | |||
| Income Before Tax | -9.89% | -23.44% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -9.89% | -23.44% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -9.89% | -23.44% | |||
| EBIT | -9.76% | -22.34% | |||
| EBITDA | -9.83% | -22.38% | |||
| EPS Basic | -9.88% | -23.46% | |||
| Normalized Basic EPS | -9.98% | -23.53% | |||
| EPS Diluted | -9.88% | -23.46% | |||
| Normalized Diluted EPS | -9.98% | -23.53% | |||
| Average Basic Shares Outstanding | 0.00% | -0.05% | |||
| Average Diluted Shares Outstanding | 0.00% | -0.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||